# EDGAR Filing Document

**Accession Number:** 0001099800
**File Stem:** 0001193125-25-174586
**Filing Date:** 2025-8
**Character Count:** 18808
**Document Hash:** c296350a4d9a1dfc92379a9c5c5e92b2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-174586.hdr.sgml**: 20250806

**ACCESSION NUMBER**: 0001193125-25-174586

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 15

**FILED AS OF DATE**: 20250806

**DATE AS OF CHANGE**: 20250806

**EFFECTIVENESS DATE**: 20250806

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Edwards Lifesciences Corp
- **CENTRAL INDEX KEY:** 0001099800
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 364316614
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-289331
- **FILM NUMBER:** 251190764

**BUSINESS ADDRESS:**
- **STREET 1:** ONE EDWARDS WAY
- **CITY:** IRVINE
- **STATE:** CA
- **ZIP:** 92614
- **BUSINESS PHONE:** 9492502500

**MAIL ADDRESS:**
- **STREET 1:** ONE EDWARDS WAY
- **CITY:** IRVINE
- **STATE:** CA
- **ZIP:** 92614

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** EDWARDS LIFESCIENCES CORP.
- **DATE OF NAME CHANGE:** 20090225

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** EDWARDS LIFESCIENCES CORP
- **DATE OF NAME CHANGE:** 20000203

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CVG CONTROLLED INC
- **DATE OF NAME CHANGE:** 19991126

**As filed with the Securities and Exchange Commission on August 6, 2025** 

**Registration No. 333-** 

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM S-8** 

**REGISTRATION STATEMENT** 

***UNDER***

***THE SECURITIES ACT OF 1933***

## EDWARDS LIFESCIENCES CORPORATION
**(Exact name of registrant as specified in its charter)** 

---

| | |
|:---|:---|
| **Delaware** | **36-4316614** |
| **(State or other jurisdiction of**<br> **incorporation or organization)** | **(I.R.S. Employer**<br> **Identification No.)** |

---

**One Edwards Way** 

**Irvine, California 92614** 

**(Address, including zip code, of Principal Executive Offices)** 

**Edwards Lifesciences Corporation** 

**2001 Employee Stock Purchase Plan for International Employees** 

**(Full title of the plan)** 

**Mark D. Peterson** 

**Corporate Vice President, General Counsel** 

**Edwards Lifesciences Corporation** 

**One Edwards Way** 

**Irvine, California 92614** 

**(949) 250-2500** 

**(Name, address and telephone number, including area code, of agent for service)** 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

------

**EXPLANATORY NOTE** 

This Registration Statement is filed by Edwards Lifesciences Corporation (the "Company" or "Registrant") to register additional securities issuable pursuant to the Edwards Lifesciences Corporation 2001 Employee Stock Purchase Plan for International Employees, as amended and restated, and consists of only those items required by General Instruction E to Form S-8.

**PART I** 

INFORMATION REQUIRED IN THE

SECTION 10(a) PROSPECTUS

The document(s) containing the information specified in Part I of Form S-8 will be sent or given to participants as specified by Rule 428(b)(1) promulgated under the Securities Act of 1933, as amended (the "Securities Act").

------

**PART II** 

INFORMATION REQUIRED IN THE

REGISTRATION STATEMENT

**Item 3.** **Incorporation of Certain Documents by Reference** <br>

The following documents of the Company filed with the Securities and Exchange Commission (the "Commission") are incorporated herein by reference:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company's Registration Statement on [Form S-8](http://www.sec.gov/Archives/edgar/data/1099800/000119312521153592/d388220ds8.htm) , filed with the Commission on May 7, 2021 (Commission File No. 333-255854);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Company's Annual Report on [Form 10-K](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001099800/000109980025000005/ew-20241231.htm) for its fiscal year ended December 31, 2024, filed with the Commission on February 28, 2025 (Commission File No. 001-15525);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The portions of the Company's Definitive Proxy Statement on [Schedule 14A](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001099800/000109980025000013/ew-20250325.htm) , filed with the Commission on March 
26, 2025, that are incorporated by reference in Part III of the Company's Annual Report on [Form 10-K](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099800/000109980025000005/ew-20241231.htm) for its fiscal year ended December 31, 2024 (Commission File No. 001-15525);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) The Company's Quarterly Reports on Form 10-Q for its fiscal
quarters ended March 31, 2025 and June 30, 2025, filed with the Commission on [May 6, 2025](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001099800/000109980025000023/ew-20250331.htm) and [August 6, 2025](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099800/000109980025000048/ew-20250630.htm) , respectively (each, Commission File No. 001-15525);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) The Company's Current Reports on Form 8-K, filed with the
Commission on [May 8, 2025](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099800/000109980025000026/ew-20250508.htm) and [July 25, 2025](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099800/000119312525164527/d66195d8k.htm) (each, Commission File No. 001-15525); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) The description of the Company's Common Stock contained in [Exhibit 4.2](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099800/000109980023000005/ew-20221231.htm) to the Company's Annual Report on Form 10-K for the year ended December 31, 2022, filed with the Commission on February 13, 2023, which updated the description thereof contained in
Post-Effective Amendment No. 1 to the Company's Registration Statement on [Form 10](http://www.sec.gov/Archives/edgar/data/1099800/000095013100002396/0000950131-00-002396.txt) , filed with the Commission on April 5, 2000
(each, Commission File No. 001-15525), and any other amendments or reports filed for the purpose of updating such description.

All documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing of such documents; provided, however, that documents or information deemed to have been furnished and not filed in accordance with Commission rules shall not be deemed incorporated by reference into this Registration Statement. Any statement contained herein or in a document, all or a portion of which is incorporated or deemed to be incorporated by reference herein, shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or amended, to constitute a part of this Registration Statement.

------

**Item 5.** **Interests of Named Experts and Counsel** <br>

The validity of the issuance of Common Stock registered hereby is passed on for the Company by Linda J. Park. Ms. Park is the Company's Senior Vice President, Associate General Counsel and Corporate Secretary and is compensated by the Company as an employee. Ms. Park has participated in and holds awards granted under the Company's equity and long-term compensation plans and owns shares of Common Stock.

**Item 8.** **Exhibits** <br>

See the attached Exhibit Index at page 5, which is incorporated herein by reference.

------

**EXHIBIT INDEX** 

---

| | |
|:---|:---|
| Exhibit<br>Number | Description of Exhibit |
| 4 | Edwards Lifesciences Corporation 2001 Employee Stock Purchase Plan for International Employees, as amended and restated February 13, 2025 (incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q for its fiscal quarter ended June 30, 2025, filed with the Commission on [August 6, 2025](http://www.sec.gov/Archives/edgar/data/1099800/000109980025000048/ex-1022001internationalesp.htm) (Commission File No. 001-15525)). |
| 5 | [Opinion of Counsel (opinion re legality).](d39572dex5.htm) |
| 23.1 | [Consent of PricewaterhouseCoopers LLP (consent of independent registered public accounting firm).](d39572dex231.htm) |
| 23.2 | [Consent of Counsel (included in Exhibit 5).](d39572dex5.htm) |
| 24 | [Power of Attorney (included in this Registration Statement under "Signatures").](#sig) |
| 107 | [Filing Fee Table](d39572dexfilingfees.htm) |

---

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Form S-8 Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Irvine, State of California, on August 6, 2025.

---

| | |
|:---|:---|
| **EDWARDS LIFESCIENCES CORPORATION** | **EDWARDS LIFESCIENCES CORPORATION** |
| By: | /s/ Linda J. Park |
|  | Linda J. Park |
|  | Senior Vice President, Associate General Counsel, and Corporate Secretary |

---

------

**POWER OF ATTORNEY** 

Each person whose signature appears below constitutes and appoints Scott B. Ullem, Mark Peterson, and Linda J. Park, and each of them, acting individually and without the other, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place, and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments, exhibits thereto and other documents in connection therewith) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them individually, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| Signature | Title | Date |
| /s/ Bernard J. Zovighian<br> Bernard J. Zovighian | Chief Executive Officer<br> (Principal Executive Officer) | August 6, 2025 |
| /s/ Scott B. Ullem<br> Scott B. Ullem | Corporate Vice President and Chief Financial Officer<br> (Principal Financial Officer) | August 6, 2025 |
| /s/ Andrew M. Dahl<br> Andrew M. Dahl | Senior Vice President, Corporate Controller<br> (Principal Accounting Officer) | August 6, 2025 |
| /s/ Leslie C. Davis<br> Leslie C. Davis | Director | August 6, 2025 |
| /s/ David T. Feinberg<br> David T. Feinberg | Director | August 6, 2025 |
| /s/ Kieran T. Gallahue<br> Kieran T. Gallahue | Director | August 6, 2025 |
| /s/ Leslie S. Heisz<br> Leslie S. Heisz | Director | August 6, 2025 |
| /s/ Paul A. LaViolette<br> Paul A. LaViolette | Director | August 6, 2025 |

---

------

---

| | | |
|:---|:---|:---|
| Signature | Title | Date |
| /s/ Steven R. Loranger<br> Steven R. Loranger | Director | August 6, 2025 |
| /s/ Ramona Sequeira<br> Ramona Sequeira | Director | August 6, 2025 |
| /s/ Nicholas J. Valeriani<br> Nicholas J. Valeriani | Director | August 6, 2025 |

---

## Ex-5

EXHIBIT 5

![LOGO](g39572g0801023914524.jpg)

August 6, 2025

Edwards Lifesciences Corporation

One Edwards Way

Irvine, California 92614

---

| | |
|:---|:---|
| Re: | ***Registration of Securities of Edwards Lifesciences Corporation***  |

---

Ladies and Gentlemen:

In connection with the registration of up to 1,460,000 shares of Common Stock of Edwards Lifesciences Corporation, a Delaware corporation (the "Company"), par value $1.00 per share (the "Shares"), under the Securities Act of 1933, as amended, pursuant to a Registration Statement on Form S-8 (the "Registration Statement"), filed with the Securities and Exchange Commission on or about the date hereof, such Shares to be issued or delivered pursuant to the 2001 Employee Stock Purchase Plan for International Employees, as amended and restated (the "Plan"), you have requested my opinion set forth below.

In my capacity as counsel, I have examined originals or copies of those corporate and other records of the Company I considered appropriate.

On the basis of such examination and my consideration of those questions of law I considered relevant, and subject to the limitations and qualifications in this opinion, I am of the opinion that the Shares have been duly authorized by all necessary corporate action on the part of the Company and, when issued in accordance with such authorization, the provisions of the Plan and relevant agreements duly authorized by and in accordance with the terms of the Plan, and upon payment for and delivery of the Shares as contemplated in accordance with the Plan, and either (a) the countersigning of the certificate or certificates representing the Shares by a duly authorized signatory of the registrar for the Company's Common Stock, or (b) the book-entry of the Shares by the transfer agent for the Company's Common Stock in the name of The Depository Trust Company or its nominee, the Shares will be validly issued, fully paid and non-assessable.

I consent to your filing this opinion as an exhibit to the Registration Statement.

---

| |
|:---|
| Respectfully submitted, |
| /s/ Linda J. Park |
| Linda J. Park |
| Senior Vice President, Associate General Counsel, and Corporate Secretary |

---

**Edwards Lifesciences Corporation** 

One Edwards Way • Irvine, CA USA • 92614

Phone: 949.250.2500 • Fax: 949.250.2525 • www.edwards.com

## Exhibit 23.1

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of Edwards Lifesciences Corporation of our report dated February 28, 2025, relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in Edwards Lifesciences Corporation's Annual Report on Form 10-K for the year ended December 31, 2024.

/s/ PricewaterhouseCoopers LLP

Irvine, California

August 6, 2025

## Ex-Filing

?xml version='1.0' encoding='ASCII'? EX-FILING FEES

---

| |
|:---|
| **Calculation of Filing Fee Tables**  |
| &nbsp;&nbsp;&nbsp;&nbsp;**S-8**  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Edwards Lifesciences Corp**  |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Security Type**  | **Security Class Title**  | **Fee Calculation Rule**  | **Amount Registered**  | **Proposed Maximum Offering Price Per Unit**  | **Maximum Aggregate Offering Price**  | **Fee Rate**  | **Amount of Registration Fee**  |
| 1 | Equity | Common Stock, par value of $1.00 per share, issuable pursuant to the Registrant's 2001 Employee Stock Purchase Plan for International Employees | Other | 1460000 | $81.17 | $118508200.00 | 0.0001531 | $18143.61 |
| Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: |  | $118508200.00  |  | $18143.61  |
| Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  |  |  |  | $0.00  |
| Net Fee Due:  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  |  |  |  | $18143.61  |

---

 **Offering Note** <br>

<sup>1</sup> (1) This Registration Statement covers, in addition to the number of shares of Edwards Lifesciences Corporation, a Delaware corporation (the "Company" or the "Registrant"), common stock, par value $1.00 per share (the "Common Stock"), stated above, options and other rights to purchase or acquire the shares of Common Stock covered by this Registration Statement and, pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), an additional indeterminate number of shares, options and rights that may be offered or issued pursuant to the 2001 Employee Stock Purchase Plan for International Employees, as amended and restated (the "Plan"), as a result of one or more adjustments under the Plan to prevent dilution resulting from one or more stock splits, stock dividends or similar transactions. (2) Estimated solely for the purpose of calculating the amount of the registration fee. The offering price per share and the aggregate offering price are based upon the average of the high and low prices of the Registrant's common stock as reported on the New York Stock Exchange on July 30, 2025, in accordance with Rule 457(c) of the Securities Act. (3) The registration fee has been calculated in accordance with Rule 457(h) and Rule 457(c) promulgated under the Securities Act.

---

| | |
|:---|:---|
| | |
| **Rule 457(p)** | **Rule 457(p)** |
| Fee Offset Claims | N/A |
| Fee Offset Sources | N/A |

---